EFM
LEGN icon

E Fund Management’s Legend Biotech LEGN Stock Holding History

E Fund Management’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.16M Buy
109,327
+79,405
+265% +$2.14M 0.07% 123
2026
Q1 		$541K Buy
+29,922
New +$570K 0.02% 279
2025
Q2 		$927K Sell
26,132
-74,038
-74% -$2.4M 0.04% 178
2025
Q1 		$3.4M Sell
100,170
-13,152
-12% -$472K 0.16% 88
2024
Q4 		$3.69M Sell
113,322
-3,423
-3% -$142K 0.19% 67
2024
Q3 		$5.69M Buy
116,745
+58,319
+100% +$3.11M 0.29% 32
2024
Q2 		$2.59M Buy
58,426
+1,374
+2% +$63.4K 0.14% 71
2024
Q1 		$3.2M Sell
57,052
-6,845
-11% -$413K 0.2% 56
2023
Q4 		$3.84M Buy
63,897
+11,138
+21% +$706K 0.24% 36
2023
Q3 		$3.54M Buy
52,759
+1,080
+2% +$75K 0.27% 33
2023
Q2 		$3.57M Sell
51,679
-3,234
-6% -$211K 0.28% 35
2023
Q1 		$2.65M Sell
54,913
-395,663
-88% -$19.4M 0.19% 48
2022
Q4 		$6.29M Buy
450,576
+417,567
+1,265% +$20.2M 0.52% 29
2022
Q3 		$1.35M Buy
33,009
+1,565
+5% +$73.5K 0.13% 75
2022
Q2 		$1.73M Buy
+31,444
New +$1.33M 0.16% 67
2022
Q1 		– Sell
-8,927
Closed -$416K – 342
2021
Q4 		$416K Buy
+8,927
New +$453K 0.01% 184

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

E Fund Management's LEGN Position: Q2 2026 in Review

E Fund Management increased its Legend Biotech (LEGN) stake by 265% in Q2 2026, buying an estimated $2.14M and bringing the position to 109,327 shares worth $3.16M. The position accounts for 0.07% of the portfolio, ranked #123.

E Fund Management first reported a position in LEGN in Q4 2021 and has held it in 16 quarters since. The position peaked at $6.29M in Q4 2022. 218 funds tracked by Wall St. Rank hold LEGN as of Q2 2026.

  • E Fund Management held 109,327 shares of Legend Biotech worth $3.16M as of Q2 2026.
  • E Fund Management bought 79,405 Legend Biotech shares in Q2 2026, an estimated $2.14M.
  • Legend Biotech made up 0.07% of E Fund Management's portfolio in Q2 2026, its #123 holding.
  • E Fund Management first reported a position in Legend Biotech in Q4 2021 and has held it in 16 quarters since.
  • E Fund Management's Legend Biotech position peaked at $6.29M in Q4 2022.
  • 218 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2026.

Based on E Fund Management's 13F filing for Q2 2026, filed 11 Aug 2026.